Racial differences in postprandial mineral ion handling in health and in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 3970-3977

  Gutiérrez, Orlando M ^a   Isakova, Tamara ^b   Smith, Kelsey ^a   Epstein, Michael ^b   Patel, Neha ^a   Wolf, Myles ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

calcium; ethnic differences; fibroblast growth factor 23; parathyroid hormone; phosphorus

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; MINERAL; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CAUCASIAN; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEGRO; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; POSTPRANDIAL STATE; PRIORITY JOURNAL; RACE DIFFERENCE; URINARY EXCRETION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CALCIUM; CASE-CONTROL STUDIES; CHRONIC DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; POSTPRANDIAL PERIOD;

EID: 78649498285     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq316     Document Type: Article

References (35)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
2. Brancati FL, Whittle JC, Whelton PK et al. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 1992; 268: 3079-3084
3. Cowie CC, Port FK, Wolfe RA et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074-1079
4. Hsu CY, Lin F, Vittinghoff E et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14: 2902-2907
5. Klag MJ, Whelton PK, Randall BL et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293-1298
6. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
7. Mehrotra R, Kermah D, Fried L et al. Racial differences in mortality among those with CKD. J Am Soc Nephrol 2008; 19: 1403-1410
8. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
9. Kao WH, Klag MJ, Meoni LA et al. MYH9 is associated with non-diabetic end-stage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192
10. Wolf M, Betancourt J, Chang Y et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008; 19: 1379-1388
11. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
12. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528
13. Schwarz S, Trivedi B, Kalanter-Zadeh K et al. Association of disorders of mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 825-831
14. Tonelli M, Sacks F, Pfeffer M et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633
15. Gutierrez OM, Isakova T, Andress DL et al. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 2008; 73: 956-962
16. Foley RN, Collins AJ, Herzog CA et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404
17. Foley RN, Wang C, Ishani A et al. NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol 2007; 18: 2575-2582
18. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20: 295-301
19. Cosman F, Morgan DC, Nieves JW et al. Resistance to bone resorb-ing effects of PTH in black women. J Bone Miner Res 1997; 12: 958-966
20. Aloia JF, Mikhail M, Pagan CD et al. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med 1998; 132: 383-389
21. Fulgoni V 3rd, Nicholls J, Reed A et al. Dairy consumption and related nutrient intake in African-American adults and children in the United States: continuing survey of food intakes by individuals 1994-1996, 1998, and the National Health and Nutrition Examination Survey 1999-2000. J Am Diet Assoc 2007; 107: 256-264
22. Bell NH, Greene A, Epstein S et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985; 76: 470-473 (Pubitemid 15227507)
23. Dawson-Hughes B, Harris SS, Finneran S et al. Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab 1995; 80: 3068-3072
24. M'Buyamba-Kabangu JR, Fagard R, Lijnen P et al. Calcium, vitamin D-endocrine system, and parathyroid hormone in black and white males. Calcif Tissue Int 1987; 41: 70-74
25. Taylor EN, Curhan GC. Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol 2007; 18: 654-659
26. Isakova T, Gutierrez O, Shah A et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 2008; 19: 615-623
27. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
28. Yeh KC, Kwan KC. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Phar-macokinet Biopharm 1978; 6: 79-98
29. Harris SS, Soteriades E, Coolidge JA et al. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab 2000; 85: 4125-4130
30. Bryant RJ, Wastney ME, Martin BR et al. Racial differences in bone turnover and calcium metabolism in adolescent females. J Clin En-docrinol Metab 2003; 88: 1043-1047
31. Bell NH, Yergey AL, Vieira NE et al. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res 1993; 8: 1111-1115
32. Heaney RP. Low calcium intake among African Americans: effects on bones and body weight. J Nutr 2006; 136: 1095-1098
33. Kronenberg HM. NPT2a-the key to phosphate homeostasis. N Engl J Med 2002; 347: 1022-1024
34. Fuleihan GE, Gundberg CM, Gleason R et al. Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab 1994; 79: 1642-1647
35. Kemp GJ, Blumsohn A, Morris BW. Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts. Clin Chem 1992; 38: 400-402